MedPath

Development of diagnostic and treatment strategy for resistant hypertensio

Not Applicable
Recruiting
Conditions
Diseases of the circulatory system
Registration Number
KCT0003300
Lead Sponsor
Yonsei University Health System, Severance Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
780
Inclusion Criteria

1. 20 years and older
2. Office SBP>130 mmHg or office DBP >90 mmHg with 3 antihypertensive medications of different classes
3. Treated hypertensive patients with 4 antihypertensive medications of difference classes including diuretics

Exclusion Criteria

1. desired life time under 6 months due to non-cardiovascular disease (e.g. cancer, sepsis)
2. women with pregnancy or on nursing
3. within the first three months after transplantation
4. acute renal allograft rejection
5. within six months after dicharge from hospitalization for acute coronary syndrome (myocardial infarction, unstable angina) or acute stroke
6. systolic heart failure (LVEF =40%)

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
"Outcome, Multiple item"_Composite of cardiovascular death, myocardial infarction, stroke, admission for heart failure
Secondary Outcome Measures
NameTimeMethod
1. Progression of CKD: Start dialysis or doubling of serum creatinine, Target organ damage: LVH confirmed by echocardiography or EKG; carotid femoral PWV= 12m/s; microalbuminuria (Urine albumin-creatinine ratio =30 mg/g),Target blood pressure: Achievement of BP below 130/80 or 140/90 mmHg
© Copyright 2025. All Rights Reserved by MedPath